Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy. by Healey, C, Sabharwal, N, Daub, J, Davidson, F, Yap, P, Fleming, K, Chapman, R, Simmonds, P, Chapel, H

“…Thirty-six patients from the United Kingdom received infusions from a batch of anti-HCV antibody-screened intravenous Ig (Gammagard; Baxter Healthcare Ltd., Thetford, Norfolk, England) that was associated with reports of acute hepatitis C outbreak in Europe. …”